News from mylan inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Jun 18, 2015, 11:55 ET

U.S. Court of Appeals for the Federal Circuit Finds Teva's '808 Copaxone® Patent Invalid

Mylan N.V. (Nasdaq: MYL) today commented on the ruling by the U.S. Court of Appeals for the Federal Circuit, which again has found Teva's U.S....

Jun 16, 2015, 09:19 ET

Mylan Issues Statement in Response to Abbott's Support for Perrigo Transaction

Mylan N.V. (NASDAQ: MYL) today issued the following statement regarding Abbott Laboratories' (NYSE: ABT) announced intention to support Mylan's...

Jun 16, 2015, 07:30 ET

Pulmatrix and Mylan Enter Into ex-U.S. Development Agreement for PUR0200

Pulmatrix (Nasdaq: PULM), a clinical stage biopharmaceutical company developing innovative inhaled therapies for serious pulmonary diseases, today...

Jun 08, 2015, 03:00 ET

Mylan Launches First Bioequivalent Alternative to Combination Asthma Therapy Seretide® Evohaler® (Salmeterol Xinafoate/Fluticasone Propionate) Under the Brand Name Sirdupla™ in the UK

 Mylan N.V. (Nasdaq: MYL) today announced that it has launched the first bioequivalent alternative to GlaxoSmithKline's Seretide®...

Jun 03, 2015, 11:00 ET

Mylan to Present at Goldman Sachs 36th Annual Global Healthcare Conference

Mylan N.V. (Nasdaq: MYL), a leading global pharmaceutical company, today announced that the Company will present at Goldman Sachs 36th Annual...

Jun 02, 2015, 15:50 ET

Mylan Launches Generic Version of Seasonique® Tablets

 Mylan N.V. (Nasdaq: MYL) today announced the U.S. launch of Levonorgestrel and Ethinyl Estradiol Tablets USP, 0.15 mg/0.03 mg and Ethinyl...

Jun 02, 2015, 15:30 ET

Mylan Launches Generic INTUNIV® Tablets

 Mylan N.V. (Nasdaq: MYL) today announced the U.S. launch of Guanfacine Extended-release Tablets, 1 mg, 2 mg, 3 mg, and 4 mg, which is the...

May 26, 2015, 16:48 ET

Mylan to Present at the Bernstein Strategic Decisions Conference

 Mylan N.V. (Nasdaq: MYL), a leading global pharmaceutical company, today announced that Mylan CEO Heather Bresch, will be presenting at the...

May 25, 2015, 09:47 ET

Mylan/Perrigo Clarification

 Mylan N.V. (NASDAQ: MYL) today announced that it was asked by the Irish Takeover Panel to issue the following clarification and retraction in...

May 12, 2015, 16:00 ET

Mylan to Present at the UBS Global Healthcare Conference

 Mylan N.V. (Nasdaq: MYL) today announced that the Company will present at the UBS Global Healthcare Conference on Monday May 18, 2015. The...

May 12, 2015, 07:30 ET

Mylan to Present at the Bank of America Merrill Lynch Health Care Conference

 Mylan N.V. (Nasdaq: MYL) today announced that the Company will present at the Bank of America Merrill Lynch Health Care Conference on...

May 07, 2015, 06:30 ET

Un ícono de la moda, una chef y un actor se unen para compartir historias personales sobre el manejo de alergias potencialmente mortales en nueva campaña

Mylan N.V. (Nasdaq: MYL), una importante compañía farmacéutica global, anunció hoy el lanzamiento de EpiPen® On...

May 07, 2015, 06:30 ET
Myland

Fashion Icon, Chef and Actor Join Together to Share Personal Stories of Managing Life-Threatening Allergies in New Campaign

 Mylan N.V. (Nasdaq: MYL), a leading global pharmaceutical company, today announced the launch of EpiPen® On Location™. This...

May 05, 2015, 16:05 ET

Mylan First Quarter 2015 Constant Currency Revenue Increases 15% and Adjusted Diluted EPS Increases 6% to $0.70

 Mylan N.V. (Nasdaq: MYL) today announced its financial results for the quarter ended March 31, 2015. Highlights - Total revenues...

May 05, 2015, 13:45 ET

Mylan Launches Generic Seasonale® Tablets

Mylan N.V. (NASDAQ: MYL) today announced the U.S. launch of Levonorgestrel and Ethinyl Estradiol Tablets USP, 0.15 mg/0.03 mg, which is the generic...

May 05, 2015, 13:15 ET

Mylan Confirms First-to-File Patent Challenge Relating to Minivelle®

Mylan N.V. (Nasdaq: MYL) today confirmed that it and its subsidiaries Mylan Pharmaceuticals Inc. and Mylan Technologies Inc. have been sued by...

May 04, 2015, 05:00 ET
Mylan Launches Gilead Sciences' Sovaldi(R) Tablets in India

Mylan Launches Gilead Sciences' Sovaldi® Tablets in India

 Mylan N.V. (Nasdaq: MYL) today announced that its subsidiary, Mylan Pharmaceuticals Private Limited, has launched Gilead Sciences' Sovaldi...

Apr 29, 2015, 09:20 ET

Mylan Raises Offer to Acquire Perrigo

 Mylan N.V. (NASDAQ: MYL) today announced that, further to its announcement issued pursuant to Rule 2.5 of the Irish Takeover Rules on...

Apr 27, 2015, 12:21 ET

Mylan Schedules First Quarter 2015 Financial Results Conference Call and Live Webcast

 Mylan N.V. (NASDAQ: MYL) announced today that it will host a conference call and live webcast on Tuesday, May 5, 2015, at 4:30 p.m. ET,...

Apr 27, 2015, 09:19 ET

Mylan Board Unanimously Rejects Unsolicited Expression of Interest from Teva

Mylan N.V. (NASDAQ: MYL) today announced that its Board of Directors has unanimously rejected the unsolicited...